The AIM-HI Accelerator Fund (AIM-HI) aims to bring together a diverse community of cancer researchers, entrepreneurs, pharmaceutical industry leaders, biotech investors, patient advocates, and supporters to accelerate the development of cancer treatments and save patients’ lives. Together with our strategic partners, the National Foundation for Cancer Research and the Asian Fund for Cancer Research Limited,…
If AngeLink has a guardian angel, she may well be Dr. Sujuan Ba, Ph.D., who was recently featured as One of the 20 Most Inspiring Women Leaders of 2022 by The Women Leaders Magazine. “Sujuan believed in my vision for AngeLink before anyone else,” says AngeLink Founder and CEO Gerry Poirier. “She is the ‘definition’…
The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award. The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next wave of innovators, by offering a range of mentoring skills including clinical trial design expertise,…
We’re excited that Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, is featured as one of the “20 Most Inspiring Women Leaders 2022” by THE WOMEN LEADERS Magazine. Read about her illustrious career leading three successful non-profits in the field of cancer research, all the while paving the way for Women in Life Sciences. Her vision has…
Together, we can make the next generation of cancer treatments a reality.